Goldman Sachs’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-14,364	Closed	-$130K	–	4487
2013 Q4	$130K	Sell	14,364 -21,252	-60%	-$192K	﹤0.01%	4030
2013 Q3	$224K	Buy	35,616 +18,774	+111%	+$118K	﹤0.01%	3773
2013 Q2	$115K	Buy	+16,842	New	+$115K	﹤0.01%	3785